Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Perskindol Cool - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Perskindol Cool

Approved

STANDARD

Perskindol Cool

Vifor SA🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5daca86e5e7b642c
Company: Vifor SA
Type: Standard

Approval Details

Approval Id: 5daca86e5e7b642c
Drug Approval Philippines Name: Perskindol Cool
Product Name: Perskindol Cool
Registration Number: DRHR-1950
Brand Name: Perskindol Cool
Generic Name: Menthol
Dosage Form: Gel
Dosage Strength: 70 mg per gram
Manufacturer: Vifor SA
Importer: Zuellig Pharma Corp.
Distributor: Zuellig Pharma Corp.
Issuance Date: 28 June 2024
Expiry Date: 09 October 2029
Pharmacologic Category: Counterirritant
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5daca86e5e7b642c

Type

Standard

Back to Philippines FDA Approvals